Breaking News, Financial News

Financial Report: BASi

Revenues up 2% driven by preclinical and bioanalytical services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BASi   3Q Revenues: $6.2 million (+2%) 3Q Earnings: $1.5 million (earnings were $215,000 3Q14) YTD Revenues: $17.7 million (-2%) YTD Earnings: $1.8 million (loss of $666,000 YTD14) Comments: Service revenue for the quarter increased 5% to $5.0 million driven by Preclinical service and Bioanalytical analysis revenues partially offset by lower other lab services revenue. Product revenue decreased 10% to $1.1 million due to lower Analytical instrument sales....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters